| Titolo | Fase | Stato | Sede patologia | Strutture coinvolte | Dettaglio |
A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL, PARALLEL GROUP, TREATMENT STUDY TO ASSESS THE EFFICACY AND SAFETY OF THE LIFILEUCEL (LN-144, AUTOLOGOUS TUMOR-INFILTRATING LYMPHOCYTES [TIL]) REGIMEN IN COMBINATION WITH PEMBROLIZUMAB COMPARED WITH PEMBROLIZUMAB MONOTHERAPY IN PARTICIPANTS WITH UNTREATED, UNRESECTABLE OR METASTATIC MELANOMA |
III |
in corso |
MELANOMA |
- SC Oncologia Clinica Sperimentale del Melanoma – Immunoterapia e Terapie Innovative |
|
STUDIO INTERVENTISTICO, NON FARMACOLOGICO, PER VALUTARE IMPACT® COME SUPPORTO AL TRATTAMENTO ANTI PD1 O A REGIMI BASATI SU ANTI PD1 IN PAZIENTI CON MELANOMA INOPERABILE LOCALMENTE AVANZATO O METASTATICO |
NA |
in corso |
MELANOMA |
SC Oncologia Clinica Sperimentale del Melanoma – Immunoterapia e Terapie Innovative - |
|
RANDOMIZED, CONTROLLED, OPEN-LABEL, PHASE III STUDY OF LURBINECTEDIN IN COMBINATION WITH DOXORUBICIN VERSUS DOXORUBICIN ALONE AS FIRST-LINE TREATMENT IN PATIENTS WITH METASTATIC LEIOMYOSARCOMA (SALUDO) |
II/III |
in corso |
leiomiosarcoma |
- SC Oncologia Clinica Sperimentale dei Sarcomi e Tumori Rari |
|
AN INTERNATIONAL PROSPECTIVE OPEN-LABEL, MULTI-CENTER, RANDOMIZED, NON-COMPARATIVE PHASE II STUDY OF LUTETIUM [177LU] VIPIVOTIDE TETRAXETAN ALONE AND LUTETIUM [177LU] VIPIVOTIDE TETRAXETAN IN COMBINATION WITH ANDROGEN RECEPTOR PATHWAY INHIBITORS (ARPI) IN PATIENTS WITH PSMA PET SCAN POSITIVE CASTRATION-RESISTANT PROSTATE CANCER (CRPC) |
II |
in corso |
CARCINOMA PROSTATICO |
- SC Oncologia Clinica Sperimentale Uro - Ginecologica |
|
ADJUVANT TRASTUZUMAB DERUXTECAN PLUS FLUOROPYRIMIDINE VERSUS STANDARD CHEMOTHERAPY IN HER2-POSITIVE GASTRIC OR GASTROESOPHAGEAL CANCER PATIENTS WITH PERSISTENCE OF MINIMAL RESIDUAL DISEASE IN LIQUID BIOPSY AFTER PREOPERATIVE CHEMOTHERAPY AND RADICAL SURGERY |
NA |
in corso |
CANCRO GASTRICO-ESOFAGEO |
- SC Oncologia Clinica Sperimentale Addominale |
